15–19 Feb 2016
Centre International de Conferences de Geneve (CICG)
Europe/Zurich timezone

Recurrent glioblastoma multiforme – targeted alpha therapy with 213Bi-DOTA-Substance P

19 Feb 2016, 09:05
20m
3 (Centre International de Conferences de Geneve (CICG))

3

Centre International de Conferences de Geneve (CICG)

International Conference Centre Geneva 17, rue de Varembé CH- 1211 Geneva 2

Speaker

Frank Bruchertseifer

Presentation materials